S-ICD System Post Approval Study (S-ICD PAS)-The primary purpose of the S-ICD Post Approval Study is to document long term safety and effectiveness outcomes associated with the implantation of the SQ-RX pulse generator and Q-TRAK electrode in a commercial clinical setting. This study is sponsored by Boston Scientific Corporation Cardiac Rhythm Management (CRM).
The use of the medication adherence score to predict non adherence in atrial fibrillation patients and improve patient selection for Watchman- Therapy (ADHERE-AF)- The aim of this study is to assess how many atrial fibrillation (AF) patients in general AF population there are with predicted low adherence using the Medication Adherence Score (MAS).
STEP STUDY- The STEP Study, sponsored by AtaCor Medical, is a first in man clinical trial evaluating the MACH I Delivery Tool combined with the STEALTH-TRAC Pacing lead as a single unit. The study enrolls up to 15 patients who will undergo acute and subacute testing of a temporary pacing systems safety and effectiveness. The Step Study is currently enrolling in Paraguay. The protocol and the device system being tested involves human prototypes that are based on the early feasibility and device development experiments that have been reported recently in Circulation: Arrhythmia and Electrophysiology.